HUYA Bioscience partners with Shanghai Zhangjiang Biotech Pharmaceutical Base

HUYA Bioscience International, jointly headquartered in Shanghai, China, and in San Diego, USA, has entered into a collaborative partnership with Shanghai Zhangjiang Biotech and Pharmaceutical Base Development and Shanghai Pharma Engine (collectively, "Zhangjiang Biotech Pharmaceutical Base").

HUYA focuses on accelerating the global development of China's pharmaceutical innovations. This new partnership will focus on innovations coming out of companies located in Zhangjiang Biotech Pharmaceutical Base that could meet critical global pharmaceutical pipeline needs.

HUYA says it is one of the first companies to have recognized China's potential to help meet the global need for new preclinical and clinical stage compounds. The company is committed to facilitating and promoting the global development and commercialization of novel pharmaceutical products originating in China. HUYA has established a series of collaborations with leading universities and research institutes throughout China and has pioneered in-licensing both preclinical and clinical stage compounds from the country, utilizing its expertise to advance these compounds for global markets.